Latest Updates and Featured News Of Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017

Researchmoz added Most up-to-date research on "Latest Updates and Featured News Of Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017" to its huge collection of research reports.

This report provides an overview of the pipeline landscape for neuropsychiatric disorders. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Attention Deficit Hyperactivity Disorder (ADHD), Depression, Schizophrenia, and Tourette syndrome, and features dormant and discontinued projects.

Attention deficit hyperactivity disorder (ADHD) is a group of behavioral symptoms that include inattentiveness, hyperactivity and impulsiveness, with symptoms including disorganized work habits, procrastination and inability to sustain attention on tasks or activities.

Depression is a mood disorder that causes a persistent feeling of sadness and loss of interest. Signs and symptoms include sleep disturbances, including insomnia or sleeping too much, changes in appetite, anxiety, agitation or restlessness and physical problems, such as back pain or headaches.

Schizophrenia is a chronic, severe, and disabling brain disorder that generally appears in late adolescence or early adulthood. Symptoms include delusions, hallucinations, disorganized speech and disorganized behavior.


To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1277497


Finally, Tourette syndrome is a neurological disorder characterized by repetitive, stereotyped, involuntary movements and vocalizations called tics. Symptoms include eye blinking and other eye movements, facial grimacing, shoulder shrugging, and head or shoulder jerking.

The size of these pipelines ranges from 11 products in Tourette syndrome to 191 in depression. Across all four of these indications, however, transporters and receptors of neurotransmitters such as dopamine and serotonin are the most common targets, closely reflecting the current treatment landscape of these diseases.

Scope
- Which companies are the most active within the pipeline for genetic neuropsychiatric disorder therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of genetic neuropsychiatric disorders?


Browse TOC @ https://www.researchmoz.us/neuropsychiatric-disorder-cluster-drug-development-pipeline-review-2017-report.html/toc


Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Major Players In Colorectal Cancer Therapeutics in Asia-Pacific Market to 2023 - Merck KGaA, Eli Lilly, Sanofi, Bayer/Onyx and Taiho Pharma

Researchmoz added Most up-to-date research on "Major Players In Colorectal Cancer Therapeutics in Asia-Pacific Market to 2023 - Merck KGaA, Eli Lilly, Sanofi, Bayer/Onyx and Taiho Pharma" to its huge collection of research reports.

Colorectal Cancer (CRC) is the most common cancer and the leading cause of cancer-related mortality globally. There were more than 1.4 million newly diagnosed CRC cases in 2012, accounting for 9.7% of the total number of cancer cases. This figure has been gradually rising in the Asia-Pacific region, with the growing elderly population and increasingly Westernized lifestyles.

CRC is a leading cause of death worldwide, accounting for 0.77 million deaths in 2015. Over half of the incident cases of CRC are diagnosed in patients over the age of 50, and as the aged population is projected to grow, the prevalence of CRC is anticipated to increase, acting as a driver for revenue growth.

The poor prognosis, particularly for patients with advanced disease, has created a pressing need for improved therapeutic options. The CRC market is therefore shifting from a focus on generic chemotherapy regimens to a complex treatment landscape based on the presence of various molecular aberrations.


To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1277494


The marketed products landscape comprises a wide range of treatment options, including EGFR-targeted therapies, angiogenesis inhibitors, multiple kinase inhibitors and new chemotherapies. In the current market, RAS-wild-type and RAS-mutant patients can be treated with angiogenesis inhibitors such as Avastin, Cyramza and Zaltrap, while patients with RAS- or KRAS-wild-type mutations can be prescribed EGFR-targeted therapies such as Erbitux and Vectibix. However, significant unmet need remains for products that can treat BRAF-mutant CRC patients. A therapy that targets mutant BRAF - encorafenib plus binimetinib - is being developed in the pipeline.

Scope
The CRC Asia-Pacific market will be valued at $7.9 billion in 2023, growing from $4.7 billion in 2016 at a CAGR of 7.9%.
- How will immune checkpoint inhibitors such as Keytruda and Tecentriq contribute to growth?
- What effect will patent expirations of currently branded therapies have on market value?
The CRC pipeline is large and diverse, with an strong presence of mAbs and targeted therapies.
- What are the common targets and mechanisms of action of pipeline therapies?
- Will the pipeline address unmet needs such as the lack of targeted therapies available for BRAF-mutant CRC patients?
- What implications will the increased focus on targeted therapies have on the future of CRC treatment?
Numerous late-stage pipeline therapies with a strong clinical record have the potential to enter the market over the forecast period.
- How have the late-stage therapies performed in clinical trials?
- How would the approval of encorafenib plus binimetinib to treat BRAF-mutant patients affect the competitive landscape, with no targeted therapy currently available to address this patient subset?
The market forecasts indicate that Japan will contribute the most to the Asia-Pacific market value due to the emergence of novel therapies.
- How will the annual cost of therapy and market size vary between the five assessed Asia-Pacific markets? 
- How could changes in risk factors such as population age, obesity and lifestyle influence the market?
Licensing deals are the most common form of strategic alliance in CRC, with total deal values ranging from under $10m to over $3 billion.
- How do deal frequency and value compare between target families and molecule types?
- What were the terms and conditions of key licensing deals?

Browse TOC @ https://www.researchmoz.us/colorectal-cancer-therapeutics-in-asia-pacific-markets-to-2023-launch-of-premium-targeted-therapies-and-increasing-prevalence-to-drive-the-market-report.html/toc

Reasons to buy
- Understand the current clinical and commercial landscape by considering disease pathogenesis, diagnosis, prognosis, and the treatment options available at each stage of diagnosis, including a clinical comparison of marketed therapies.
- Visualize the composition of the CRC market in terms of the dominant therapies for each patient subset, along with their clinical and commercial standing. Unmet needs are highlighted to allow a competitive understanding of gaps in the market.
- Analyze the CRC pipeline and stratify pipeline therapies by stage of development, molecule type and molecular target.
- Understand the potential of late-stage therapies with extensive profiles of products that could enter the market over the forecast period, highlighting clinical performance, potential commercial positioning, and how they will compete with other therapies.
- Predict CRC market growth in the five assessed Asia-Pacific markets, with epidemiological and annual cost of therapy forecasts across India, China, Australia, South Korea and Japan, as well as the individual contributions of promising late-stage molecules to market growth.
- Identify commercial opportunities in the CRC deals landscape by analyzing trends in licensing and co-development deals.

Genetic Ophthalmology Disorders Drug Development Pipeline Review Focuses On Top Manufacturers - Acucela Inc, Editas Medicine Inc, Copernicus Therapeutics Inc and Grupo Ferrer Internacional SA

Researchmoz added Most up-to-date research on "Genetic Ophthalmology Disorders Drug Development Pipeline Review Focuses On Top Manufacturers - Acucela Inc, Editas Medicine Inc, Copernicus Therapeutics Inc and Grupo Ferrer Internacional SA" to its huge collection of research reports.

This report provides an overview of the pipeline landscape for genetic ophthalmological disorders. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Stargardt disease, Leber congenital amaurosis, Lebers hereditary optic neuropathy, Usher Syndrome and Retinitis pigmentosa, and features dormant and discontinued projects.

Juvenile macular degeneration is a series of inherited eye disorders that affects children and young adults, with the most common form being Stargardt disease, an inherited autosomal recessive syndrome. Leber congenital amaurosis primarily affects the retina, which is the specialized tissue at the back of the eye that detects light and color. It is the most common cause of inherited blindness in childhood. Lebers hereditary optic neuropathy usually begins in a person's teens or twenties, rare cases may appear in early childhood or later in adulthood. Usher syndrome is characterized by hearing impairment and progressive vision loss. The major symptoms of Usher syndrome are hearing loss and secondary retinitis pigmentosa. Finally, retinitis pigmentosa refers to a group of diseases which cause a slow but progressive vision loss. Symptoms include night blindness and loss of peripheral vision.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1277495

The size of these pipelines ranges from six products in Usher syndrome to 54 in retinitis pigmentosa. Gene therapies represent the most common type of therapy among these diseases, followed by small molecules. This reflects the therapeutic aim of repairing the defective gene in order to correct the patients phenotype. Likewise, the molecular targets which are acted on are typically clustered around the causative gene within each disease, although there are exceptions. Within retinitis pigmentosa in particular, there is a diversity of molecular targets.

Scope
- Which companies are the most active within the pipeline for genetic ophthalmological disorder therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of genetic ophthalmological disorders?

Browse TOC @ https://www.researchmoz.us/genetic-ophthalmology-disorders-drug-development-pipeline-review-2017-report.html/toc

Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Hepatitis Drug Development Pipeline Review Forecast By Top Leading Manufacturers | Altimmune Inc, Benitec Biopharma, Celltrion Inc and Johnson & Johnson

Researchmoz added Most up-to-date research on "Hepatitis Drug Development Pipeline Review Forecast By Top Leading Manufacturers | Altimmune Inc, Benitec Biopharma, Celltrion Inc and Johnson & Johnson" to its huge collection of research reports.

Hepatitis Drug Development

This report provides an overview of the hepatitis pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for hepatitis A, B, C and D, and features dormant and discontinued projects.

Hepatitis is a contagious viral infection affecting the liver, which may spread on contact with infected blood. It may be a mild condition or may extend over a longer span of time leading to various complications. The characteristic symptoms include abdominal pain, fatigue, fever, jaundice, loss of appetite, nausea and vomiting. The predisposing factors of hepatitis typically include dialysis, organ transplant and blood transfusion and the offspring of an infected mother also has high chances of contracting the disease.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1277496

Owing to differences in prevalence, hepatitis A and D have far smaller pipelines than hepatitis B and C; the size of these pipelines ranges from seven products in hepatitis A to 182 in hepatitis B and 199 in hepatitis C. Many of the companies who are actively fielding products in the larger two hepatitis subtypes are simultaneously developing products for both. While in hepatitis A, B and D, viral surface antigens and interferons are commonly targeted, a far wider range of proteins, including non-structural proteins, are the most common targets in hepatitis C.

Scope
- Which companies are the most active within the pipeline for hepatitis therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of hepatitis?

Browse TOC @ https://www.researchmoz.us/hepatitis-drug-development-pipeline-review-2017-report.html/toc

Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Global VR Content Creation Market Growth Opportunities, Trends by Manufacturers | Koncept VR, VOXELUS., SubVRsive, Panedia Pty Ltd., WEMAKEVR and 360 Labs

Researchmoz added Most up-to-date research on "Global VR Content Creation Market Growth Opportunities, Trends by Manufacturers | Koncept VR, VOXELUS., SubVRsive, Panedia Pty Ltd., WEMAKEVR and 360 Labs" to its huge collection of research reports.

VR content creation market report provides analysis for the period 2014 – 2024, wherein the period from 2016 to 2024 is the forecast and 2015 is the base year. The report covers all the major trends and technologies playing influential role in the VR content creation market’s growth over the forecast period. It also highlights the drivers, restraints, and opportunities expected to impact market’s growth during the said period. The study provides a complete perspective on global VR content creation market’s evolution throughout the above mentioned forecast period in terms of revenue (in US$ Mn).

This report provides all the essential information required to understand the key developments in the VR content creation market, growth trend of each segment and companies’ strategies to efficiently compete in the market. Also, the report provides insights related to trends and its impact on the market. Furthermore, Porter’s Five Forces analysis explains the factors which are currently affecting the VR content creation market.

VR Content Creation Market: Scope of the Report         

The market overview section of the report demonstrates the market dynamics such as the drivers, restraints, and opportunities that influence the current nature and future status of this market, key indicators and trends. An attractiveness analysis has also been provided for every segment in the report, in order to give a thorough understanding of the overall scenario for VR content creation market. Moreover, the report provides an overview of the various strategies adopted by key players present in the market. Key market indicators included in the report provide significance of the factors which are capable of changing the market scenario. These indicators are expected to define the market position during the forecast period.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1031492

The report also highlights the competitive landscape of the global VR content creation market, thereby positioning all the major players according to their presence in the different regions of the world and recent key developments initiated by them in VR content creation market. The comprehensive VR content creation market estimates are the result of our in-depth secondary research, primary interviews, and in-house expert panel reviews. These market estimates have been analyzed by taking into account the impact of different political, social, economic, technological, and legal factors along with the current market dynamics affecting the Americas data center market growth.

VR Content Creation Market: Key Market Segments     

The report segments the market on the basis of solution basis of content type, solution, and end-use sector. The content type segment include videos, 360 Degree Photos and games. The video segment is further sub-segmented into 360 Degree and immersive videos. On the basis of solution, the market is segmented into software/application and services. The end use sector considered in the market include real-estate, travel, hospitality and events, media and entertainment, retail, gaming, automotive and others. The report provides in-depth segment analysis of the global VR content creation market, thereby providing valuable insights at the macro as well as micro levels.

Browse TOC @ https://www.researchmoz.us/vr-content-creation-market-global-industry-analysis-size-share-growth-trends-and-forecast-2016-2024-report.html/toc

VR Content Creation Market: Companies Mentioned in Report

Koncept VR, VOXELUS., SubVRsive, Panedia Pty Ltd., WEMAKEVR, 360 Labs, MATTERVR and Elysian Studio Private Limited (Meraki), Matterport, Wevr, Vizor, and Blippar are some of the major players operating within the VR content creation market profiled in this study. Details such as financials, SWOT analysis, business strategies, recent developments, and other such strategic information pertaining to these players has been duly provided as part of company profiling.

Global VR Content Creation Market

By Content Type

• Videos
• 360 Degree
• Immersive
• 360 Degree Photos
• Games 

By Solution

• Software/Application
• Services

By End-Use Sector

• Real Estate
• Travel, Hospitality and Events
• Media and Entertainment
• Retail
• Gaming
• Automotive
• Others

Pharmaceuticals and Healthcare: Hepatitis Drug Development Pipeline Review, 2017

Researchmoz added Most up-to-date research on "Pharmaceuticals and Healthcare: Hepatitis Drug Development Pipeline Review, 2017" to its huge collection of research reports.

This report provides an overview of the hepatitis pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for hepatitis A, B, C and D, and features dormant and discontinued projects.

Hepatitis is a contagious viral infection affecting the liver, which may spread on contact with infected blood. It may be a mild condition or may extend over a longer span of time leading to various complications. The characteristic symptoms include abdominal pain, fatigue, fever, jaundice, loss of appetite, nausea and vomiting. The predisposing factors of hepatitis typically include dialysis, organ transplant and blood transfusion and the offspring of an infected mother also has high chances of contracting the disease.

Owing to differences in prevalence, hepatitis A and D have far smaller pipelines than hepatitis B and C; the size of these pipelines ranges from seven products in hepatitis A to 182 in hepatitis B and 199 in hepatitis C. Many of the companies who are actively fielding products in the larger two hepatitis subtypes are simultaneously developing products for both. While in hepatitis A, B and D, viral surface antigens and interferons are commonly targeted, a far wider range of proteins, including non-structural proteins, are the most common targets in hepatitis C.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1277496

Scope
- Which companies are the most active within the pipeline for hepatitis therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of hepatitis?

Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Browse TOC @ https://www.researchmoz.us/hepatitis-drug-development-pipeline-review-2017-report.html/toc

Table of Contents
GBI Research Report Guidance 2
Executive Summary 3
Table of Contents 4
List of Tables 6
List of Figures 11
Introduction 12
Hepatitis Report Coverage 12
Hepatitis A - Overview 12
Hepatitis B - Overview 12
Hepatitis C - Overview 12
Hepatitis D - Overview 12
Therapeutics Development 13
Hepatitis A 13
Hepatitis B 17
Hepatitis C 30
Hepatitis D 43
Therapeutics Assessment 46

Banknote Market: Global Industry Analysis, Market Size, Share, Growth, Trends and Forecast, 2017

Researchmoz added Most up-to-date research on "Banknote Market: Global Industry Analysis, Market Size, Share, Growth, Trends and Forecast, 2017" to its huge collection of research reports.

Banknote is a promissory note which is issued by banks that is payable on demand to the bearer. The production and distribution of new banknotes and destruction of the unfit banknotes is the responsibility of the central bank of the respective countries. The demand for banknotes and substrate is fulfilled by state print works (SPW), state paper mills (SPM) and few commercial print and paper manufacturers. SPWs and SPMs can also turn in to commercial providers to cater the unmet demand for banknotes.

Major factors contributing to the growth of the market include increasing domestic transactions and increasing demand for foreign currencies across different countries. The global financial crisis led to a one-time increase in the demand for these notes, thereby leading to increased market value.
The report “Global Banknote Market” provides a comprehensive study of banknote market globally. It also provides detailed information for key regional markets of banknote industry. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The four major players in the industry, De La Rue plc, Geisecke & Devrient Group and Fortress Paper Ltd. are being profiled.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1129608

The key factors driving the growth of banknote market are financial instability of the economy and GDP of the economy. Some of the noteworthy trends and developments of this industry are adoption of polymer banknotes and new banknotes developments. However, the expansion of banknote market is hindered by rise of digital or cashless payment, secured production of banknotes and overcapacity.

Table of Content

1. Banknote Market - An Overview
1.1 An Introduction
1.2 Banknote Manufacturing Process
1.3 Banknote Printing, Packaging and Waste Management
1.4 Banknote Distribution Logistics Model

Browse TOC @ https://www.researchmoz.us/global-banknote-market-report-2017-edition-report.html/toc

2. Global Banknote Market Analysis
2.1 COEFER of Major Currencies Worldwide
2.2 Share of Currencies Worldwide
2.3 Global Banknote Substrate Market by Segments
2.4 Global Banknote Market by Threads

3. Regional Market Analysis 
3.1 The US
3.1.1 Annual Production Volume of US Currency Notes
3.1.2 Production Share of US Currency Notes by Denomination
3.1.3 Production Value of US Currency Notes by Denomination
3.2 The Eurozone
3.2.1 Euro Banknotes Production Volume
3.2.2 Euro Banknotes Production Share by Denomination
3.2.3 Value of Euro Banknotes Produced in the Eurozone
3.3 The UK

Comprehensive Study Of Banknote Market Globally | ResearchMoz

Researchmoz added Most up-to-date research on "Comprehensive Study Of Banknote Market Globally | ResearchMoz" to its huge collection of research reports.

Banknote is a promissory note which is issued by banks that is payable on demand to the bearer. The production and distribution of new banknotes and destruction of the unfit banknotes is the responsibility of the central bank of the respective countries. The demand for banknotes and substrate is fulfilled by state print works (SPW), state paper mills (SPM) and few commercial print and paper manufacturers. SPWs and SPMs can also turn in to commercial providers to cater the unmet demand for banknotes.

Major factors contributing to the growth of the market include increasing domestic transactions and increasing demand for foreign currencies across different countries. The global financial crisis led to a one-time increase in the demand for these notes, thereby leading to increased market value.

The report “Global Banknote Market” provides a comprehensive study of banknote market globally. It also provides detailed information for key regional markets of banknote industry. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The four major players in the industry, De La Rue plc, Geisecke & Devrient Group and Fortress Paper Ltd. are being profiled.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1129608

The key factors driving the growth of banknote market are financial instability of the economy and GDP of the economy. Some of the noteworthy trends and developments of this industry are adoption of polymer banknotes and new banknotes developments. However, the expansion of banknote market is hindered by rise of digital or cashless payment, secured production of banknotes and overcapacity.

Table of Content

1. Banknote Market - An Overview
1.1 An Introduction
1.2 Banknote Manufacturing Process
1.3 Banknote Printing, Packaging and Waste Management
1.4 Banknote Distribution Logistics Model

2. Global Banknote Market Analysis
2.1 COEFER of Major Currencies Worldwide
2.2 Share of Currencies Worldwide
2.3 Global Banknote Substrate Market by Segments
2.4 Global Banknote Market by Threads

3. Regional Market Analysis 
3.1 The US
3.1.1 Annual Production Volume of US Currency Notes
3.1.2 Production Share of US Currency Notes by Denomination
3.1.3 Production Value of US Currency Notes by Denomination
3.2 The Eurozone
3.2.1 Euro Banknotes Production Volume
3.2.2 Euro Banknotes Production Share by Denomination

Browse More Details @ https://www.researchmoz.us/global-banknote-market-report-2017-edition-report.html

Analysis Of High Intensity Focused Ultrasound (HIFU): By Manufacturers - EDAP TMS, Sonacare Medical, Haifu & Insightec

Researchmoz added Most up-to-date research on "Analysis Of High Intensity Focused Ultrasound (HIFU): By Manufacturers - EDAP TMS, Sonacare Medical, Haifu & Insightec" to its huge collection of research reports.

High-Intensity Focused Ultrasound (HIFU) is an FDA-approved, minimally invasive therapeutic technology with the potential to transform the treatment of many medical disorders by using ultrasonic energy to target tissue. Till date more than 100,000 patients have been treated with HIFU therapeutic technology; nearly 25,000 patients alone treated in 2015. New regulatory approvals in United States and other part of the world, expansion of research and treatment sites and innovation continues in new companies are some the growth driving factors for HIFU devices.

Prostate Cancer is the Leading use of HIFU Technology Globally 
Prostate cancer is one of the common types of cancer in the men. Prostate cancer begins when cells in the prostate gland start to grow uncontrollably. It is estimated that nearly 161,360 new cases of prostate cancer will be found in the United States and nearly 26,730 men is expected to die in 2017.

About One Third of the Total HIFU Patients are Treated for Uterine Fibroids Cases in 2015
Uterine fibroids are benign tumors that originate in the uterus. Most of the women did not found any symptoms whereas some women have painful period. The exact cause of uterine fibroids is unclear. Uterine fibroids are the other leading application for HIFU device. About one third of the total HIFU patients are treated for uterine fibroids cases in 2015.

Nearly One Third of the Total HIFU Manufacturers are based in European region 
At present 36 companies are manufacturing HIFU device globally. Nearly one third of the total manufacturers are based in European region. France and United States are two most favorable places for HIFU manufacturers in European and North American region.

High Intensity Focused Ultrasound (HIFU) Product Analysis of 20 Manufacturers & Deals is the 2nd edition report on High-Intensity Focused Ultrasound (HIFU) by Renub Research. This 150 page report contains 17 Figures and 14 Tables it provides a detailed analysis of the HIFU products of the companies. This report provides the latest available and emerging High Intensity Focused Ultrasound products being utilized by the HIFU centers. Each company is discussed in depth with a section on its product line, revenue and latest development in HIFU market.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1129607

All the High Intensity Focused Ultrasound (HIFU) in the report has been studied from 7 viewpoints

1. HIFU Manufacturers, Research Sites, Pre–Clinical Research Sites, Clinical Research Sites, Technical Research Sites & Commercial Treatment Sites
2. Major Deals (Collaboration Deals, Distribution Agreement Deals, Partnerships Deals) – 2012-2017
3. HIFU Products
4. HIFU Patents and Intellectual Property 
5. HIFU Clinical & Regulatory Status 
6. Companies HIFU Revenue
7. Latest Development in High Intensity Focus Ultrasound (HIFU)

20 High Intensity Focused Ultrasound (HIFU) Manufacturers studied in the report is as follows

1. EDAP TMS
2. Sonacare Medical
3. Haifu
4. Insightec 
5. Theraclion
6. Alpinion 
7. Shanghai A&S Co., LTD
8. Mianyang Sonic Electronic Ltd 
9. Eye Tech Care
10. FUS Instruments
11. Image Guided Therapy
12. Philips Healthcare
13. Profound Medical Corp
14. Promedica Bioelectronics
15. Shenzhen PRO-HIFU Medical Tech. Co., Ltd.
16. Shenzhen Wikkon
17. Sonic Concepts
18. Verasonics
19. Changjiangyuan Technology Development Co., Ltd
20. EpiSonica

This report provides the answer of following questions

• How many HIFU research sites are currently working across various world regions and in globe? 
• What are the company’s latest developments in the HIFU segments?
• What is the advantage of the each HIFU manufacturer products?
• How many HIFU clinical research sites are currently working across various world regions and in globe? 
• What are the company’s latest developments in the HIFU segments?
• How many HIFU commercial treatment sites are currently working across various world regions and in globe? 
• What are the company’s latest developments in the HIFU segments?
• What is the advantage of the each HIFU manufactures products?
• How many HIFU products are available for the particular company?
• What is the HIFU product regulatory status for the particular company?

Browse More Details @ http://www.researchmoz.us/high-intensity-focused-ultrasound-hifu-product-analysis-of-20-manufacturers-deals-report.html

Glaucoma In Global Market: Industry Analysis, Size, Trends & Outlook, 2017 - 2021

Researchmoz added Most up-to-date research on "Glaucoma In Global Market: Industry Analysis, Size, Trends & Outlook, 2017 - 2021" to its huge collection of research reports.

Glaucoma is a group of eye diseases which result in damage to the optic nerve and vision loss. The most common type is open-angle glaucoma with less common types including closed-angle glaucoma and normal-tension glaucoma. Open-angle glaucoma develops slowly over time and there is no pain. Side vision may begin to decrease followed by central vision resulting in blindness, if not treated. Closed-angle glaucoma can present gradually or suddenly. The sudden presentation may involve severe eye pain, blurred vision, mid-dilated pupil, redness of the eye, and nausea. Vision loss from glaucoma, once it has occurred, is permanent.

Though, glaucoma cannot be cured completely but the disease progression can be controlled with the help of available treatments. There are three types of modalities available for treatment of glaucoma: Drugs, Laser and Invasive Surgery. Further, based upon the approaches employed for the medication, it can be segmented into two parts: PGA Medication and Non-PGA Medication. The PGA approach reduces IOP with the help of prostaglandin (PGA). The non-PGA medication can be further divided into four sub segments: Beta blockers, Alpha blockers, Carbonic anhydrase inhibitors (CAIs) and Combination Products.

Several factors such as rising prevalence of diabetes, growing geriatric population and rising health care expenditure along with increasing disposable income and growing obese population will drive the market growth in the next few years. Development of new drugs & devices and drug therapy focused upon IOP are the few notable market trends. However, high cost of treatment, severe side effects and hasty drug approval processes act as a major roadblock for the market growth.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1109589

The report “Global Glaucoma Market: Industry Analysis & Outlook (2017-2021)” analyzes the development of this market, with focus on the US and OUS treatment market. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Pfizer Inc., Novartis AG, Merck & Co., Inc. and Allergan Plc. are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global glaucoma market along with the study of the US market.

Table of Content

1. Overview
1.1 Glaucoma
1.2 Causes & Types
1.3 Symptoms & Diagnosis
1.4 Treatment Methods
1.5 Glaucoma Pharmaceutical Market Segmentation

2. Global Glaucoma Market
2.1 Global Glaucoma Market Forecast by Value
2.2 Global Glaucoma Market by Segments
2.3 Global Glaucoma Drugs Market Forecast by Value
2.4 Global Glaucoma Market by Drug Class
2.5 Global Glaucoma Drugs Market by Region
2.6 Global Glaucoma Patient Volume Forecast

3. Regional Markets
3.1 The US
3.1.1 The US Glaucoma Drugs Market Forecast by Value
3.1.2 The US Glaucoma Patient Volume Forecast
3.1.3 The US Open Angle Glaucoma Patient Volume Forecast
3.1.4 The US Glaucoma Prescription Volume Forecast
3.1.5 The US Glaucoma Drugs Market by Type

Browse More Details @ http://www.researchmoz.us/global-glaucoma-market-industry-analysis-outlook-20172021-report.html

Comprehensive Study Of Global Banknote Market, 2017: Major Players - De La Rue plc, Geisecke & Devrient Group and Fortress Paper Ltd.

Researchmoz added Most up-to-date research on "Comprehensive Study Of Global Banknote Market, 2017: Major Players - De La Rue plc, Geisecke & Devrient Group and Fortress Paper Ltd." to its huge collection of research reports.

Banknote is a promissory note which is issued by banks that is payable on demand to the bearer. The production and distribution of new banknotes and destruction of the unfit banknotes is the responsibility of the central bank of the respective countries. The demand for banknotes and substrate is fulfilled by state print works (SPW), state paper mills (SPM) and few commercial print and paper manufacturers. SPWs and SPMs can also turn in to commercial providers to cater the unmet demand for banknotes.

Major factors contributing to the growth of the market include increasing domestic transactions and increasing demand for foreign currencies across different countries. The global financial crisis led to a one-time increase in the demand for these notes, thereby leading to increased market value.
The report “Global Banknote Market” provides a comprehensive study of banknote market globally. It also provides detailed information for key regional markets of banknote industry. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The four major players in the industry, De La Rue plc, Geisecke & Devrient Group and Fortress Paper Ltd. are being profiled.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1129608

The key factors driving the growth of banknote market are financial instability of the economy and GDP of the economy. Some of the noteworthy trends and developments of this industry are adoption of polymer banknotes and new banknotes developments. However, the expansion of banknote market is hindered by rise of digital or cashless payment, secured production of banknotes and overcapacity.

Table of Content

1. Banknote Market - An Overview
1.1 An Introduction
1.2 Banknote Manufacturing Process
1.3 Banknote Printing, Packaging and Waste Management
1.4 Banknote Distribution Logistics Model

2. Global Banknote Market Analysis
2.1 COEFER of Major Currencies Worldwide
2.2 Share of Currencies Worldwide
2.3 Global Banknote Substrate Market by Segments
2.4 Global Banknote Market by Threads

3. Regional Market Analysis 
3.1 The US
3.1.1 Annual Production Volume of US Currency Notes
3.1.2 Production Share of US Currency Notes by Denomination
3.1.3 Production Value of US Currency Notes by Denomination
3.2 The Eurozone
3.2.1 Euro Banknotes Production Volume

Browse More Details @ http://www.researchmoz.us/global-banknote-market-report-2017-edition-report.html

Advances in Hepatitis Drug Development For 2017: An Industrial Update

Researchmoz added Most up-to-date research on "Advances in Hepatitis Drug Development For 2017: An Industrial Update" to its huge collection of research reports.

This report provides an overview of the hepatitis pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for hepatitis A, B, C and D, and features dormant and discontinued projects.

Hepatitis is a contagious viral infection affecting the liver, which may spread on contact with infected blood. It may be a mild condition or may extend over a longer span of time leading to various complications. The characteristic symptoms include abdominal pain, fatigue, fever, jaundice, loss of appetite, nausea and vomiting. The predisposing factors of hepatitis typically include dialysis, organ transplant and blood transfusion and the offspring of an infected mother also has high chances of contracting the disease.

Owing to differences in prevalence, hepatitis A and D have far smaller pipelines than hepatitis B and C; the size of these pipelines ranges from seven products in hepatitis A to 182 in hepatitis B and 199 in hepatitis C. Many of the companies who are actively fielding products in the larger two hepatitis subtypes are simultaneously developing products for both. While in hepatitis A, B and D, viral surface antigens and interferons are commonly targeted, a far wider range of proteins, including non-structural proteins, are the most common targets in hepatitis C.

Scope
- Which companies are the most active within the pipeline for hepatitis therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of hepatitis?

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1277496

Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Table of Contents

GBI Research Report Guidance 2
Executive Summary 3
Table of Contents 4
List of Tables 6
List of Figures 11
Introduction 12
Hepatitis Report Coverage 12
Hepatitis A - Overview 12
Hepatitis B - Overview 12
Hepatitis C - Overview 12
Hepatitis D - Overview 12
Therapeutics Development 13
Hepatitis A 13
Hepatitis B 17
Hepatitis C 30
Hepatitis D 43

Browse More Details @ http://www.researchmoz.us/hepatitis-drug-development-pipeline-review-2017-report.html

2017: Comprehensive Study Of Global Banknote Market Include Increasing Domestic Transactions As Well As Demand For Foreign Currencies Across Different Countries

Researchmoz added Most up-to-date research on "2017: Comprehensive Study Of Global Banknote Market Include Increasing Domestic Transactions As Well As Demand For Foreign Currencies Across Different Countries" to its huge collection of research reports.

Banknote is a promissory note which is issued by banks that is payable on demand to the bearer. The production and distribution of new banknotes and destruction of the unfit banknotes is the responsibility of the central bank of the respective countries. The demand for banknotes and substrate is fulfilled by state print works (SPW), state paper mills (SPM) and few commercial print and paper manufacturers. SPWs and SPMs can also turn in to commercial providers to cater the unmet demand for banknotes.

Major factors contributing to the growth of the market include increasing domestic transactions and increasing demand for foreign currencies across different countries. The global financial crisis led to a one-time increase in the demand for these notes, thereby leading to increased market value.
The report “Global Banknote Market” provides a comprehensive study of banknote market globally. It also provides detailed information for key regional markets of banknote industry. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The four major players in the industry, De La Rue plc, Geisecke & Devrient Group and Fortress Paper Ltd. are being profiled.

The key factors driving the growth of banknote market are financial instability of the economy and GDP of the economy. Some of the noteworthy trends and developments of this industry are adoption of polymer banknotes and new banknotes developments. However, the expansion of banknote market is hindered by rise of digital or cashless payment, secured production of banknotes and overcapacity.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1129608

Table of Content

1. Banknote Market - An Overview
1.1 An Introduction
1.2 Banknote Manufacturing Process
1.3 Banknote Printing, Packaging and Waste Management
1.4 Banknote Distribution Logistics Model

2. Global Banknote Market Analysis
2.1 COEFER of Major Currencies Worldwide
2.2 Share of Currencies Worldwide
2.3 Global Banknote Substrate Market by Segments
2.4 Global Banknote Market by Threads

3. Regional Market Analysis 
3.1 The US
3.1.1 Annual Production Volume of US Currency Notes
3.1.2 Production Share of US Currency Notes by Denomination
3.1.3 Production Value of US Currency Notes by Denomination
3.2 The Eurozone
3.2.1 Euro Banknotes Production Volume
3.2.2 Euro Banknotes Production Share by Denomination
3.2.3 Value of Euro Banknotes Produced in the Eurozone
3.3 The UK
3.3.1 Stock of Notes in Circulation in the UK by Value

Browse More Details @ http://www.researchmoz.us/global-banknote-market-report-2017-edition-report.html

Therapeutic Technologies For High Intensity Focused Ultrasound (HIFU) Product: Analysis of 20 Manufacturers & Deals

Researchmoz added Most up-to-date research on "Therapeutic Technologies For High Intensity Focused Ultrasound (HIFU) Product: Analysis of 20 Manufacturers & Deals" to its huge collection of research reports.

High-Intensity Focused Ultrasound (HIFU) is an FDA-approved, minimally invasive therapeutic technology with the potential to transform the treatment of many medical disorders by using ultrasonic energy to target tissue. Till date more than 100,000 patients have been treated with HIFU therapeutic technology; nearly 25,000 patients alone treated in 2015. New regulatory approvals in United States and other part of the world, expansion of research and treatment sites and innovation continues in new companies are some the growth driving factors for HIFU devices.

Prostate Cancer is the Leading use of HIFU Technology Globally 
Prostate cancer is one of the common types of cancer in the men. Prostate cancer begins when cells in the prostate gland start to grow uncontrollably. It is estimated that nearly 161,360 new cases of prostate cancer will be found in the United States and nearly 26,730 men is expected to die in 2017.

About One Third of the Total HIFU Patients are Treated for Uterine Fibroids Cases in 2015
Uterine fibroids are benign tumors that originate in the uterus. Most of the women did not found any symptoms whereas some women have painful period. The exact cause of uterine fibroids is unclear. Uterine fibroids are the other leading application for HIFU device. About one third of the total HIFU patients are treated for uterine fibroids cases in 2015.

Nearly One Third of the Total HIFU Manufacturers are based in European region 
At present 36 companies are manufacturing HIFU device globally. Nearly one third of the total manufacturers are based in European region. France and United States are two most favorable places for HIFU manufacturers in European and North American region.

High Intensity Focused Ultrasound (HIFU) Product Analysis of 20 Manufacturers & Deals is the 2nd edition report on High-Intensity Focused Ultrasound (HIFU) by Renub Research. This 150 page report contains 17 Figures and 14 Tables it provides a detailed analysis of the HIFU products of the companies. This report provides the latest available and emerging High Intensity Focused Ultrasound products being utilized by the HIFU centers. Each company is discussed in depth with a section on its product line, revenue and latest development in HIFU market.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1129607

All the High Intensity Focused Ultrasound (HIFU) in the report has been studied from 7 viewpoints

1. HIFU Manufacturers, Research Sites, Pre–Clinical Research Sites, Clinical Research Sites, Technical Research Sites & Commercial Treatment Sites
2. Major Deals (Collaboration Deals, Distribution Agreement Deals, Partnerships Deals) – 2012-2017
3. HIFU Products
4. HIFU Patents and Intellectual Property 
5. HIFU Clinical & Regulatory Status 
6. Companies HIFU Revenue
7. Latest Development in High Intensity Focus Ultrasound (HIFU)

20 High Intensity Focused Ultrasound (HIFU) Manufacturers studied in the report is as follows

1. EDAP TMS
2. Sonacare Medical
3. Haifu
4. Insightec 
5. Theraclion
6. Alpinion 
7. Shanghai A&S Co., LTD
8. Mianyang Sonic Electronic Ltd 
9. Eye Tech Care
10. FUS Instruments
11. Image Guided Therapy
12. Philips Healthcare
13. Profound Medical Corp
14. Promedica Bioelectronics
15. Shenzhen PRO-HIFU Medical Tech. Co., Ltd.
16. Shenzhen Wikkon
17. Sonic Concepts
18. Verasonics
19. Changjiangyuan Technology Development Co., Ltd
20. EpiSonica

This report provides the answer of following questions

• How many HIFU research sites are currently working across various world regions and in globe? 
• What are the company’s latest developments in the HIFU segments?
• What is the advantage of the each HIFU manufacturer products?
• How many HIFU clinical research sites are currently working across various world regions and in globe? 
• What are the company’s latest developments in the HIFU segments?

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1129607

2017: Global Artemisia Annua Industry Including Capacity, Production, Production Value, Cost/Profit, Supply/Demand And Chinese Import/Export

Researchmoz added Most up-to-date research on "2017: Global Artemisia Annua Industry Including Capacity, Production, Production Value, Cost/Profit, Supply/Demand And Chinese Import/Export" to its huge collection of research reports.

The 'Global and Chinese Artemisia Annua  Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Artemisia Annua  industry with a focus on the Chinese market. The report provides key statistics on the market status of the Artemisia Annua  manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview of the industry including its definition, applications and manufacturing technology.

Then, the report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2012-2017 market shares for each company. Through the statistical analysis, the report depicts the global and Chinese total market of Artemisia Annua industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, and by application/type for the competitive landscape analysis. The report then estimates 2017-2022 market development trends of Artemisia Annua industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out. In the end, the report makes some important proposals for a new project of Artemisia Annua Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2012-2022 global and Chinese Artemisia Annua industry covering all important parameters.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1114817

Table Of Content

Chapter One Introduction of Artemisia Annua
 Industry
1.1 Brief Introduction of Artemisia Annua
1.2 Development of Artemisia Annua
 Industry
1.3 Status of Artemisia Annua
 Industry

Chapter Two Manufacturing Technology of Artemisia Annua
2.1 Development of Artemisia Annua
 Manufacturing Technology
2.2 Analysis of Artemisia Annua
 Manufacturing Technology
2.3 Trends of Artemisia Annua
 Manufacturing Technology

Chapter Three Analysis of Global Key Manufacturers
3.1 Company A
3.1.1 Company Profile
3.1.2 Product Information
3.1.3 2012-2017 Production Information
3.1.4 Contact Information
3.2 Company B
3.2.1 Company Profile
3.2.2 Product Information
3.2.3 2012-2017 Production Information
3.2.4 Contact Information
3.3 Company C
3.2.1 Company Profile
3.3.2 Product Information
3.3.3 2012-2017 Production Information
3.3.4 Contact Information

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1114817

Comprehensive Analysis & Treatments Available For Global Glaucoma Market: Industry Analysis & Outlook, 2017 - 2021

Researchmoz added Most up-to-date research on "Comprehensive Analysis & Treatments Available For Global Glaucoma Market: Industry Analysis & Outlook, 2017 - 2021" to its huge collection of research reports.

Glaucoma is a group of eye diseases which result in damage to the optic nerve and vision loss. The most common type is open-angle glaucoma with less common types including closed-angle glaucoma and normal-tension glaucoma. Open-angle glaucoma develops slowly over time and there is no pain. Side vision may begin to decrease followed by central vision resulting in blindness, if not treated. Closed-angle glaucoma can present gradually or suddenly. The sudden presentation may involve severe eye pain, blurred vision, mid-dilated pupil, redness of the eye, and nausea. Vision loss from glaucoma, once it has occurred, is permanent.

Though, glaucoma cannot be cured completely but the disease progression can be controlled with the help of available treatments. There are three types of modalities available for treatment of glaucoma: Drugs, Laser and Invasive Surgery. Further, based upon the approaches employed for the medication, it can be segmented into two parts: PGA Medication and Non-PGA Medication. The PGA approach reduces IOP with the help of prostaglandin (PGA). The non-PGA medication can be further divided into four sub segments: Beta blockers, Alpha blockers, Carbonic anhydrase inhibitors (CAIs) and Combination Products.

Several factors such as rising prevalence of diabetes, growing geriatric population and rising health care expenditure along with increasing disposable income and growing obese population will drive the market growth in the next few years. Development of new drugs & devices and drug therapy focused upon IOP are the few notable market trends. However, high cost of treatment, severe side effects and hasty drug approval processes act as a major roadblock for the market growth.

The report “Global Glaucoma Market: Industry Analysis & Outlook (2017-2021)” analyzes the development of this market, with focus on the US and OUS treatment market. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Pfizer Inc., Novartis AG, Merck & Co., Inc. and Allergan Plc. are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global glaucoma market along with the study of the US market.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1109589

Table of Content

1. Overview
1.1 Glaucoma
1.2 Causes & Types
1.3 Symptoms & Diagnosis
1.4 Treatment Methods
1.5 Glaucoma Pharmaceutical Market Segmentation

2. Global Glaucoma Market
2.1 Global Glaucoma Market Forecast by Value
2.2 Global Glaucoma Market by Segments
2.3 Global Glaucoma Drugs Market Forecast by Value
2.4 Global Glaucoma Market by Drug Class
2.5 Global Glaucoma Drugs Market by Region
2.6 Global Glaucoma Patient Volume Forecast

3. Regional Markets
3.1 The US
3.1.1 The US Glaucoma Drugs Market Forecast by Value
3.1.2 The US Glaucoma Patient Volume Forecast
3.1.3 The US Open Angle Glaucoma Patient Volume Forecast
3.1.4 The US Glaucoma Prescription Volume Forecast
3.1.5 The US Glaucoma Drugs Market by Type
3.1.6 The US Glaucoma First Line Drugs Market Forecast by Value

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1109589

New Study On Military Ground Robot Mobile Platform Systems to Engage Terrorists: Market Shares, Strategies, Forecasts & Worldwide, 2015 to 2021

ResearchMoz presents this most up-to-date research on "New Study On Military Ground Robot Mobile Platform Systems to Engage Terrorists: Market Shares, Strategies, Forecasts & Worldwide, 2015 to 2021".

WinterGreen Research announces that it has published a new study on Military Ground Robot Mobile Platform Systems of Engagement: Market Shares, Strategies, and Forecasts, Worldwide, 2015-2021. The 2015 study has 644 pages, 302 tables and figures. Worldwide markets are poised to achieve significant change as platforms of engagement leverage military grade mobile robotic device capabilities in the fight against terrorism. WinterGreen Research, Inc. Economies of scale and new levels of protection availability are provided by military robots. Military robot target markets are military, government, and commercial. Funding sources for military robots are likely to expand beyond the army to the state department and the intelligence community. Beyond that, virtually every government department is likely to purchase military robots. Funding sources for military robots become more widely dispersed than has been the case with military purchases by the cold war military industrial complex. Instead of a very few large defense contractors fighting for each large contract award, military robots represent adaptations of competitive bidding to suit the military needs for a robot. Some funding may come from organizations like the FAA, the agriculture department, the CDC, and other government agencies that have outreach responsibility.

The point is that military robots are affordable, useful, flexible, able to be re-purposed, and extremely effective in the field. The military robots that are lasting are those implemented as a versatile platform ready to combat terrorism wherever it appears. Terrorists feed on the unexpected. As a military robotic platform technology that accepts multiple different modules, robots can be repurposed within minutes in the event of a terrorist attack. A traditional IED military robot deterrent may not be the most effective in a terrorist situation. With a robotic platform approach, the army can respond to situations that are creating the need for flexible, general purpose military response to threats. The military robots can change their purpose to meet a need that might not even have been thought of before the need arose. The military robots are helping change the definition of what an army does to protect a nation. Terrorists are among the forces that have changed the role of the army altogether. Not only terrorists, but world economic changes to industrial footprints, military responsiveness needs change rapidly. Armies with military might remain the only way for a country to enforce protection of its economic interests, it ships, its manufacturing, its trading capabilities, and its borders. Without a military and strong military allies, a country has no standing in the world economy. It has no way to protect the integrity of its borders. It has no way to protect its citizens. Military strength remains dependent on ships, aircraft, and a good army.

The military robots support an army and the other branches of the armed forces as well. Military robots will to some extent leverage existing civilian technology, repurposing common devices to create a military robotic platform. The US army is embroiled in change of a different order – downsizing its size, downsizing the number of soldiers deployed. This is an all-consuming task, not leaving much bandwidth for the leadership to think about how to combat terrorism with robots. The leadership of the army does have the idea that downsizing will free up budget to invest in technology. All that labor cost needs to go away in order to invest in technology. When the army leadership does turn its attention to technology, it will see that the need is to complement the air force drones with a ground force of military robotic automated process implementation unlike anything we have ever seen before is the way to go.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=245067

The modular approach to implementing a robot that can be controlled remotely is the ideal way to address the new challenges the military encounters. Instead of building a new duplicate communications network, the military can leverage existing global civilian networks, funding modest changes to those existing networks, making them better for the military, regional and local law enforcement agencies, and the civilians. According to Susan Eustis, the lead author of the study, “the military robot purchase is driven by the need for modernization of the military. The new military is dependent on flexibility and early response. The use of military robots is based on providing a robot that is less expensive to put in the field than a trained soldier and supporting the desire to keep the trained soldiers out of harm’s way. That automation of process and modernization has appeal to those who run the military.” As nations test their ability to annex neighbors, negotiated resolution to conflict depends on the relative military strength of all the interested parties. Military robots are a key aspect of an evolving global need for military presence everywhere Military ground robot market growth comes from the inherent advantages provided by technology.

The increasingly global nature of science, technology and engineering is a reflection of the implementation of the globally integrated enterprise. Customers trust wintergreen research to work alongside them to ensure the success of the participation in a particular market segment. WinterGreen Research supports various market segment programs; provides trusted technical services to the marketing departments. It carries out accurate market share and forecast analysis services for a range of commercial and government customers globally. These are all vital market research support solutions requiring trust and integrity.

Companies Profiled

Market Leaders

• General Dynamics Northrop Grumman / Romotec
• BAE Versa / Allen Vanguard 
• Qinetiq / Foster Miller Lockheed Martin
• iRobot Kongsberg 
• Telerob ReconRobotics

Market Participants

• Boston Dynamics
• ECA Robotics
• Elbit Systems
• G-NIUS
• ICOR Technology
• Kairos Autonami 
• Mesa Robotics
• Pearson Engineering

Key Topics

• Military Ground Robots
• Military Bomb Detection
• Robots
• Networks of Military Robots
• Unmanned Military Logistics
• Vehicles

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=245067